Fig. 5From: Intranasal immunization with recombinant Toxoplasma gondii actin depolymerizing factor confers protective efficacy against toxoplasmosis in miceProtection of the mice immunized with rTgADF against oral challenge. The mice were intranasally immunized with PBS or 30 μg of rTgADF. a Survival curves of the mice (n = 22) challenged with 4 × 104 tachyzoites (acute infection) and observed daily for mortality. b Abundance of tachyzoites was detected in the liver and brain of the mice (n = 8) after being challenged with 1 × 104 tachyzoites (chronic infection). Results are expressed as mean ± SD values. *, P < 0.05 compared to the PBS groupBack to article page